Ibnsina Pharma (EGX: ISPH)

Ibnsina Pharma Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	914.94	1,131	541.21	468.54	270.88	118.46
Cash & Short-Term Investments	914.94	1,131	541.21	468.54	270.88	118.46
Cash Growth	26.31%	108.93%	15.51%	72.97%	128.66%	22.61%
Accounts Receivable	14,433	9,761	5,775	5,743	3,267	2,517
Other Receivables	0.01	0.01	0.07	-	0.37	0.37
Receivables	14,433	9,761	5,775	5,743	4,831	4,458
Inventory	6,301	3,195	2,614	2,359	2,101	1,691
Prepaid Expenses	39.62	28.39	38.8	46.45	33.84	12.66
Other Current Assets	1,472	1,823	1,543	1,061	655.1	650.96
Total Current Assets	23,160	15,937	10,511	9,678	7,891	6,930
Property, Plant & Equipment	2,554	2,184	2,156	1,468	1,227	1,121
Long-Term Investments	16.04	15.92	-	-	-	-
Other Intangible Assets	214.95	219.02	30.18	15.3	6.9	8.49
Long-Term Deferred Tax Assets	162.87	114.4	82	59.39	11.58	9.26
Total Assets	26,161	18,550	12,864	11,284	9,250	8,170
Accounts Payable	6,871	3,661	1,593	1,399	917.38	1,222
Accrued Expenses	159.7	123.05	63.21	43.42	37.42	26.72
Short-Term Debt	3,010	3,165	2,290	1,568	607.9	276.91
Current Portion of Long-Term Debt	12,596	8,673	6,339	5,910	5,691	4,633
Current Portion of Leases	212.25	117.94	90.41	71.2	15.36	15.49
Current Income Taxes Payable	88.34	79.91	26.73	59.55	34.77	50.74
Current Unearned Revenue	37.87	17.96	16.77	15.32	-	-
Other Current Liabilities	154.06	85.74	50.93	335.18	149.79	146.23
Total Current Liabilities	23,129	15,924	10,470	9,401	7,454	6,370
Long-Term Debt	85.92	556.02	852.18	204.83	405.68	515.38
Long-Term Leases	1,123	620.42	281.67	224.8	26.27	34.12
Other Long-Term Liabilities	-	-	0	-	-	26.95
Total Liabilities	24,338	17,101	11,604	9,831	7,886	6,947
Common Stock	252	252	279.04	240	240	205
Additional Paid-In Capital	237.41	237.41	277.5	277.5	277.5	277.5
Retained Earnings	1,505	1,131	901.63	948.62	847.4	740.74
Treasury Stock	-171.64	-171.64	-198.69	-14.4	-	-
Total Common Equity	1,823	1,449	1,259	1,452	1,365	1,223
Minority Interest	0	0	0.39	1.77	0	-
Shareholders' Equity	1,823	1,449	1,260	1,453	1,365	1,223
Total Liabilities & Equity	26,161	18,550	12,864	11,284	9,250	8,170
Total Debt	17,027	13,133	9,853	7,979	6,746	5,474
Net Cash (Debt)	-16,112	-12,002	-9,312	-7,510	-6,475	-5,356
Net Cash Per Share	-15.98	-11.91	-9.24	-5.77	-5.78	-4.78
Filing Date Shares Outstanding	1,008	1,008	1,008	1,226	1,120	1,120
Total Common Shares Outstanding	1,008	1,008	1,008	1,226	1,120	1,120
Working Capital	30.63	12.98	41.39	276.74	437.88	560.3
Book Value Per Share	1.81	1.44	1.25	1.18	1.22	1.09
Tangible Book Value	1,608	1,230	1,229	1,436	1,358	1,215
Tangible Book Value Per Share	1.60	1.22	1.22	1.17	1.21	1.08
Land	93.75	93.75	93.75	93.75	93.75	93.75
Buildings	816.05	807.75	724.3	692.7	654.85	601.61
Machinery	895.11	828.47	648.61	612.95	539.63	428.37
Construction In Progress	206.03	427.51	944.81	242.88	219.92	160.91

Source: S&P Capital IQ. Standard template. Financial Sources.